drugset / Trial / NCT02244866

Efficacy of Pergoveris in Aged IVF Patients

NCT02244866

Completed 240 enrolled Vietnam National University
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the efficacy between LH supplementation (Pergoveris) and non-LH supplementation (Follitropin alpha) in patients aged ≥ 35 years undergoing IVF treatment. Study hypothesis: Pergoveris (LH supplementation) is better than follitropin alpha (non-LH supplementation) for ovarian stimulation in aged IVF patients.

Timeline

Start
2012-10
Primary completion
2014-04
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gonal-f Protein / enzyme biologic 150 iu Subcutaneous
Comparator Recombinant LH Protein / enzyme biologic 75 iu Subcutaneous

Indications